INTS6

Integrator complex subunit 6 · Q9UL03 · INTS6 on Sugi Atlas →

0 patent compounds predicted against INTS6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to INTS6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) PHASE2COMPLETED
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer PHASE1ACTIVE_NOT_RECRUITING
Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Short-Term Application of Tocilizumab Following Myocardial Infarction nanCOMPLETED
The Role of TBC1D4 in Exercise- and Insulin-induced Glucose Metabolism in Human Skeletal Muscle nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Gene Expression in Obesity and Insulin Resistance nanCOMPLETED
Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing nanRECRUITING
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients nanCOMPLETED
Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico nanCOMPLETED
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib nanRECRUITING
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581 nanCOMPLETED
Genetic Analysis of Hereditary Non-Syndromic Oral Clefts nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Impact of Comprehensive Intervention on the Cardiometabolic Risk in Children With Central Obesity (IGENOI)Obesity nanCOMPLETED
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Biomarkers in Patients With Rhabdomyosarcoma nanCOMPLETED
Monogenic Diabetes Misdiagnosed as Type 1 nanRECRUITING
Defining an Obesity QTL on Chromosome 3q nanCOMPLETED
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a INTS6 binder may also engage these)

ProteinNameSimilarity
Q6PCM2 1.000 Q6PCM2 →
Q5U4W6 1.000 Q5U4W6 →
Q2TAF4 1.000 Q2TAF4 →
Q7SYD9 1.000 Q7SYD9 →
Q5JSJ4 0.993 Q5JSJ4 →
Q8BND4 0.987 Q8BND4 →
Q6DEZ2 0.982 Q6DEZ2 →
B5DDX6 0.981 B5DDX6 →
Q99P88 0.980 Q99P88 →
Q921C3 0.980 Q921C3 →
Q6NRE7 0.979 Q6NRE7 →
Q5RHQ8 0.978 Q5RHQ8 →
Q66IV1 0.978 Q66IV1 →
Q5PQS6 0.978 Q5PQS6 →
Q9H8E8 0.978 Q9H8E8 →
Q7Z5Y7 0.977 Q7Z5Y7 →
NUP155 Nuclear pore complex protein Nup155 0.977 landscape →
Q8K2L8 0.977 Q8K2L8 →
P31266 0.977 P31266 →
Q9W0E3 0.977 Q9W0E3 →
DOCK11 Dedicator of cytokinesis protein 11 0.977 landscape →
P37199 0.977 P37199 →
Q8CID0 0.977 Q8CID0 →
A2AF47 0.976 A2AF47 →
Q6DC03 0.976 Q6DC03 →
Q9NVU0 0.976 Q9NVU0 →
Q58A65 0.976 Q58A65 →
Q5EY87 0.976 Q5EY87 →
Q80ZD1 0.976 Q80ZD1 →
Q86UW7 0.976 Q86UW7 →